![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Augmentation of Interferon signaling pathway by Nitazoxanide: A therapeutic strategy for HIV/HCV Coinfected Relapsers to Peg-interferon and Ribavirin therapy.
|
|
|
Reported by Jules Levin
CROI 2012 March 5-8 Seattle WA
1,2Osinusi A, 1Wang C, 1Zhang X, 1Shivabesan G, 1Shivakumar B, 2Silk R, 3Doonquah, L, 4Henn S, 5Teferi, G, 6Masur H, 1Kottilil S, 2Fishbein D1LIR,NIAID, NIH, Bethesda, MD, 2 Clinical Research Directorate/CMRP, SAIC-Frederick, NCI-Frederick, Frederick, MD, 3Family & Medical Counseling Service, Washington DC,4Whitman Walker Clinic, Washington DC, 5Unity Healthcare, Inc, Washington DC, 6CCMD, CC, NIH, Bethesda, MD.
![CROI1.gif](../images/040212/040212-3/CROI1.gif)
![CROI2.gif](../images/040212/040212-3/CROI2.gif)
![CROI3.gif](../images/040212/040212-3/CROI3.gif)
![CROI4.gif](../images/040212/040212-3/CROI4.gif)
![CROI5.gif](../images/040212/040212-3/CROI5.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|